Digital therapeutics, or DTx, is a hot topic in the scientific world, drawing attention from all over. This review dives into what DTx is and how it can help treat various diseases, comparing it to traditional drug treatments. It also looks at the good and bad parts of the current European laws on DTx.

DTx is like a new tool in the healthcare toolbox. It uses digital technology, like apps and software, to treat diseases. This is different from traditional medicines that you take by mouth or injection. The idea is to use these digital tools to improve or even replace those traditional treatments.

In Europe, laws on DTx are still being figured out. Some countries have made progress, but others are still trying to understand how to regulate these new methods. This review highlights the strengths and weaknesses of the current situation. For example, some countries are moving fast, while others are taking their time.

One of the big questions is how effective DTx really is. Can it replace traditional treatments, or is it better used alongside them? This review looks at both sides of the story, trying to answer these questions. It's a complex topic, with a lot of factors to consider.

Another important point is how these digital tools can be used to gather data. This data can be used to improve treatments, but it also raises questions about privacy and security. The review touches on these issues, encouraging critical thinking about the future of digital therapeutics.

Digital Medicine: A New Player in Europe's Healthcare

Actions